Physitrack PLC (PTRK.ST)
SEK 12.45
(0.4%)
SEK 12.45
(0.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.04 Million EUR | 1098.08% |
| 2022 | 253.92 Thousand EUR | 101.91% |
| 2021 | -13.32 Million EUR | -1214.49% |
| 2020 | 1.19 Million EUR | 195.18% |
| 2019 | 405 Thousand EUR | 28.06% |
| 2018 | 316.25 Thousand EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 100.0% |
| 2015 | -704.86 Thousand EUR | -0.34% |
| 2014 | -702.45 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 3.76 Million EUR | 23.1% |
| 2024 Q1 | 3.05 Million EUR | 0.42% |
| 2023 Q3 | 3.34 Million EUR | 10.82% |
| 2023 FY | 3.04 Million EUR | 1098.08% |
| 2023 Q1 | 2.29 Million EUR | 802.72% |
| 2023 Q4 | 3.04 Million EUR | -9.12% |
| 2023 Q2 | 3.02 Million EUR | 31.79% |
| 2022 Q3 | -252.37 Thousand EUR | 93.87% |
| 2022 Q1 | -8.54 Million EUR | 35.83% |
| 2022 FY | 253.92 Thousand EUR | 101.91% |
| 2022 Q4 | 253.92 Thousand EUR | 200.61% |
| 2022 Q2 | -4.11 Million EUR | 51.83% |
| 2021 Q1 | 1.04 Million EUR | -12.96% |
| 2021 FY | -13.32 Million EUR | -1214.49% |
| 2021 Q3 | -15.79 Million EUR | -1603.06% |
| 2021 Q4 | -13.32 Million EUR | 15.62% |
| 2021 Q2 | 1.05 Million EUR | 0.96% |
| 2020 Q1 | 12.25 Thousand EUR | 0.0% |
| 2020 FY | 1.19 Million EUR | 195.18% |
| 2020 Q4 | 1.19 Million EUR | 0.0% |
| 2019 FY | 405 Thousand EUR | 28.06% |
| 2018 FY | 316.25 Thousand EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2016 FY | - EUR | 100.0% |
| 2015 FY | -704.86 Thousand EUR | -0.34% |
| 2014 FY | -702.45 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aino Health AB (publ) | -1.27 Million SEK | 339.354% |
| Bonzun AB (publ) | 351 Thousand SEK | -766.72% |
| Kontigo Care AB (publ) | -3.9 Million SEK | 177.965% |
| Medhelp Care Aktiebolag (publ) | -8.26 Million SEK | 136.808% |
| RaySearch Laboratories AB (publ) | 185.67 Million SEK | 98.362% |
| Surgical Science Sweden AB (publ) | -581.1 Million SEK | 100.524% |